SC 13D

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

February 19, 2014

Accession Number

0001144204-14-010610

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →